COVID-19

Outside of the loss of human life due to the COVID-19 pandemic, the past two years have greatly affected hospitals, health systems and the way providers deliver care. Healthcare executives are grappling with federal monetary assistance, growing burnout rates, workforce shortages and federal oversight of vaccines and testing. This channel is also designed to update clinicians on new research and guidelines regarding COVID patient treatment strategies and risk assessments.

RSS icon

Myocarditis risk higher after COVID-19 infection than after vaccination, new study of 43 million patients confirms

The new analysis, published in Circulation, confirmed that vaccine-related myocarditis is incredibly rare.

PET imaging uncovers a surprising new way COVID-19 affects the heart

A new study in JACC: Cardiovascular Imaging focuses on a potential new side effect of COVID-19, highlighting the continued importance of monitoring these patients going forward. 

COVID-19 medical imaging examples of various clinical presentations. SARS-CoV-2 clinical imaging presentations.

PHOTO GALLERY: What does COVID-19 look like on medical imaging?

This image gallery shows what the various clinical presentations associated with the COVID-19 virus that have been documented during the coronavirus pandemic.

Cardiologist’s false claims used to promote fake COVID-19 vaccine recall, fact-checking website says

Footage of the cardiologist, who has gained significant popularity for speaking out against the U.S. government's response to COVID-19, is now being used to promote claims about a global recall.

What new research tells us about the significant heart damage associated with COVID-19

“We found direct evidence that the SARS-CoV-2 spike protein is toxic to heart muscle cells," one researcher said. 

High blood pressure more than doubles risk of COVID-19 hospitalization

Adults that received three doses of an mRNA COVID vaccine were 2.6 times as likely to be hospitalized if they also had high blood pressure. 

New data highlights the continued importance of COVID-19 vaccines for CVD patients

A Hong Kong study examined incidence rate ratios for major adverse cardiovascular events in the 27 days following each vaccine dose. 

Novavax NVX-CoV2373 COVID-19 vaccine myocarditis

FDA committee backs Novavax's COVID-19 vaccine despite heart damage concerns

The committee's approval comes days after the FDA shared details on a small number of trial participants who developed myocarditis or pericarditis after receiving the vaccine.  

Displaying 49 - 56 of 427

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.